ARCHIVES

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

This article is from The Cancer Letter archive.

Vol. 11 No. 32 | August 9, 1985

Download PDF Visit The Full Archive

Related Articles

Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations

June 28, 2013

Copyright Violation Of Cancer Letter – Results In Payment

July 19, 1991

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 12, 1990

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975

Bennett, Federal Prosecutors Reach $475,000 Settlement

October 31, 2014